Renal Cell Carcinoma
Conditions
Interventions
Diagnosed with renal cell carcinoma and the clinical stage T1a (tumors less than 4 cm) N0M0 or T1b (diameter 4 cm to 7 cm), solitary tumors should be performed robot-assited partial nephrectomy under
Sponsors
Jichi Medical University, Saitama Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. diagnosed with renal cell carcinoma and the clinical stage T1a (tumors less than 4 cm) N0M0 or T1b (diameter 4 cm to 7 cm), solitary tumors allows partial resection. 2. age of 20 years or more. 3. written informed consent obtained from the individual persons.
Exclusion criteria
Exclusion criteria: 1. the patient seems to be difficult to surgery due to previous surgery. 2. activity of heavy multiple cancer among patients. 3.6 months undergoing treatment for kidney cancer. 4. patients with possible discontinuation of anticoagulants. 5. patients requiring blood transfusion anemia or tendency of bleeding. 6. morbid obesity (BMI35 or higher) 7. kidney transplantation history. 8. dialysis patients. 9. pregnant women or pregnant or lactating women 10. patients with a mental illness or psychiatric symptoms. 11. patients have serious complications (angina pectoris, myocardial infarction, serious arrhythmias, uncontrolled diabetes, malignant hypertension, etc.), surgical treatment is difficult. 12. patients who have renal dysfunction (serum creatinine values:1.5mg/dl more), liver function (AST, ALT:100IU/l). 13. patients with bacterial infections require treatment. 14. patients with interstitial Pneumonitis or pulmonary fibrosis. 15. patients with severe drug hypersensitivity, drug allergies. 16. patients with under 20 years old. 17. patient deemed unfit for this protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intra-and postoperative complications and its contents | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of general anesthesia, operation time, bleeding, renal ischemic time, frequency of postoperative analgesic use, postoperative hospitalization period, perioperative renal function (before surgery (pre-operative surgery 12 weeks before),the day before surgery, on the day of the surgery, the day after surgery, the surgery three days after, the surgery six days later, after one month, three months after surgery)serum creatinine, eGFR), and before surgery (pre-operative surgery 12 weeks before), the day of one month, three months after surgery of renal scintigraphy), pathology findings | — |
Countries
Japan
Contacts
Public ContactTomoaki Miyagawa
Jichi Medical University, Saitama Medical Center Department of Urology
Outcome results
None listed